A double-blind, placebo-controlled trial of triheptanoin in adult polyglucosan body disease and open-label, long-term outcome

Skeletal muscle disorders of glycogenolysis and glycolysis

(2016) Richard Godfrey et al.   Nature Reviews Neurology

Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency

(2015) Fanny Mochel et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Triheptanoin improves brain energy metabolism in patients with Huntington disease

(2015) I. M. Adanyeguh et al.   NEUROLOGY

Contributions of glycogen to astrocytic energetics during brain activation

(2014) Gerald A. Dienel et al.   METABOLIC BRAIN DISEASE

Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings

(2012) Fanny Mochel et al.   ANNALS OF NEUROLOGY

Abnormal glycogen in astrocytes is sufficient to cause adult polyglucosan body disease

(2012) Linda Dainese et al.   GENE

The 6-min walk distance in healthy subjects: reference standards from seven countries

(2010) C. Casanova et al.   EUROPEAN RESPIRATORY JOURNAL

Adult Polyglucosan Body Disease (APBD): Anaplerotic diet therapy (Triheptanoin) and demonstration of defective methylation pathways

(2010) Charles R. Roe et al.   MOLECULAR GENETICS AND METABOLISM

Glycogen metabolism: Metabolic coupling between astrocytes and neurons

(2010) E. E. Benarroch   NEUROLOGY

Carnitine palmitoyltransferase II deficiency: Successful anaplerotic diet therapy

(2008) C. R. Roe et al.   NEUROLOGY